Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Elevated BANCR expression levels have different effects on papillary thyroid carcinoma progression depending on the presence of the BRAFV600E mutation.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology - 1 Oct 2020

Stojanović Stefana, Šelemetjev Sonja, Đorić Ilona, Rončević Jelena, Janković Miljuš Jelena, Živaljević Vladan, Išić Denčić Tijana

Abstract excerpt

INTRODUCTION: The role of BRAF-activated non-protein coding RNA (BANCR) in papillary thyroid carcinoma (PTC) is controversial, its clinical significance is unclear and no study has correlated the presence of the BRAFV600E mutation in PTC with BANCR expression. METHODS: BANCR levels in PTC and matched nonmalignant thyroid epithelial tissues from 85 patients were determined using quantitative RT-PCR. BRAFV600E was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Lymphatic Metastasis
Share to Neoplasm Invasiveness

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasm Staging

Share to Proto-Oncogene Proteins B-raf

Share to RNA, Long Noncoding

Share to Thyroid Cancer, Papillary

Share to Thyroid Neoplasms

Share to Up-Regulation

Source

Identifiers

PMID: 32651027
DOI: 10.1016/j.ejso.2020.05.027

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Elevated BANCR expression levels have different effects on papillary thyroid carcinoma progression depending on the presence of the BRAFV600E mutation.PMID 32651027Read ↗

BRAFV600E mutation, BRAF-activated long non-coding RNA and miR-9 expression in papillary thyroid carcinoma, and their association with clinicopathological features.Semantic proximity Read ↗

BRAF-Activated Long Noncoding RNA Modulates Papillary Thyroid Carcinoma Cell Proliferation through Regulating Thyroid Stimulating Hormone ReceptorSemantic proximity Read ↗

Identification of Long Noncoding RNAs Deregulated in Papillary Thyroid Cancer and Correlated with BRAFV600E Mutation by Bioinformatics Integrative Analysis.Semantic proximity Read ↗

Diagnostic accuracy in BRAF V600E-negative papillary thyroid cancer via 5-gene expression profiling of residual nucleic acids from mutation testing: a retrospective study.Semantic proximity Read ↗

Significance of the BRAF mRNA Expression Level in Papillary Thyroid Carcinoma: An Analysis of The Cancer Genome Atlas Data.Semantic proximity Read ↗

Differential microRNA expression for diagnosis and prognosis of papillary thyroid cancerSemantic proximity Read ↗

Downregulation and the Diagnostic Value of RMST in Patients with Papillary Thyroid CancerSemantic proximity Read ↗

Effect of BRAFV600E mutation on transcription and post-transcriptional regulation in a papillary thyroid carcinoma model.Semantic proximity Read ↗

Gene Expression Profiles of AHNAK2, DCSTAMP, FN1, and TERT Correlate With Mutational Status and Recurrence in Papillary Thyroid Carcinoma.Semantic proximity Read ↗

New global analysis of the microRNA transcriptome of primary tumors and lymph node metastases of papillary thyroid cancer.Semantic proximity Read ↗

Interaction of BRAF-induced ETS factors with mutant TERT promoter in papillary thyroid cancerSemantic proximity Read ↗

Upregulation of lncRNA BANCR associated with the lymph node metastasis and poor prognosis in colorectal cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.